Evolution of implants and advancements for osseointegration: A narrative review.


Journal

Injury
ISSN: 1879-0267
Titre abrégé: Injury
Pays: Netherlands
ID NLM: 0226040

Informations de publication

Date de publication:
Nov 2022
Historique:
received: 18 03 2022
revised: 24 05 2022
accepted: 26 05 2022
pubmed: 11 8 2022
medline: 18 10 2022
entrez: 10 8 2022
Statut: ppublish

Résumé

Since ancient times, reduction and internal fixation has been applied to restore skeletal integrity. Despite advances in the understanding of fracture healing, the risk of complication such as implant loosening or implant-related infection still depicts a challenging complication. Nowadays, a great deal of research is devoted to unreveal the impact of implant surface modifications on osteogenic processes to enhance bone consolidation and osseointegration. This narrative review is aimed to (1) show the evolution and already achieved milestones of implant optimization, and (2) to outline the key factors that contribute to an enhanced osseointegration. Different physical and chemical roughening techniques are currently applied in various studies. Surface patterning on the nanoscale has been found to be an essential factor for the biological response, achievable by e.g. anodisation or laser texturing. Besides surface roughening, also different coating methods are vastly investigated. Next to metal or inorganic compounds as coating material, a variety of biomolecules is currently studied for their osteosupportive capacities. Osseointegration can be improved by surface modification on the micro and nanoscale. Bioactive agents can further improve the osseointegration potential. Used agents at the moment are e.g. inorganic compounds, growth factors (BMPs and non-BMPs) and antiresorptive drugs. The advancement in research on new implant generations therefore aims at actively supporting osseointegration processing.

Identifiants

pubmed: 35948509
pii: S0020-1383(22)00532-0
doi: 10.1016/j.injury.2022.05.057
pii:
doi:

Substances chimiques

Bone Density Conservation Agents 0
Coated Materials, Biocompatible 0
Titanium D1JT611TNE

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

S69-S73

Informations de copyright

Copyright © 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare no conflict of interest

Auteurs

Nike Walter (N)

Department of Trauma Surgery, University Medical Centre, Regensburg, Germany.

Theresia Stich (T)

Department of Trauma Surgery, University Medical Centre, Regensburg, Germany.

Denitsa Docheva (D)

Department of Musculoskeletal Tissue Regeneration, Orthopaedic Hospital König-Ludwig-Haus, University of Wuerzburg, Wuerzburg, Germany.

Volker Alt (V)

Department of Trauma Surgery, University Medical Centre, Regensburg, Germany.

Markus Rupp (M)

Department of Trauma Surgery, University Medical Centre, Regensburg, Germany. Electronic address: markus.rupp@ukr.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH